Search research articles
Contact Us
Filters
Showing results (41-50 of 136) with videos related to
Page
of 14
Sort By:
Clinical Lung Cancer
|
August 1, 2024
Current Trial Report: A Multicenter Phase I/Ib study of Capmatinib Plus Trametinib in Patients With Metastatic Nonsmall Cell Lung Center Harboring MET Exon 14 Skipping Mutations and Other MET-Alterations
Matthew S Lara, Jonathan W Riess, Jonathan W Goldman, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 8, 2015
Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug-drug interaction
Millie Das, Sukhmani K Padda, Adam Frymoyer, et al.
The Oncologist
|
March 16, 2018
Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck
Vanessa Trieu, Harlan Pinto, Jonathan W Riess, et al.
Arzneimittel-Forschung
|
July 1, 1986
[The percutaneous absorption of diclofenac]
W Riess, K Schmid, L Botta, et al.
Anticancer Research
|
February 11, 2015
GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray
Jonathan W Riess, Robert West, Michelle Dean, et al.
JTO Clinical and Research Reports
|
September 10, 2025
Older Adult Participation in Early-Phase Lung Cancer Clinical Trials, 1998 to 2020
Desirae Ehley, Lilit Vardanyan, Rebecca S Boxer, et al.
Npj Metabolic Health and Disease
|
May 27, 2024
Potential roles of sex-linked differences in obesity and cancer immunotherapy: revisiting the obesity paradox
Logan V Vick, Spencer Rosario, Jonathan W Riess, et al.
Clinical Lung Cancer
|
November 2, 2013
Acquired resistance to targeted therapies against oncogene-driven non-small-cell lung cancer: approach to subtyping progressive disease and clinical implications
David R Gandara, Tianhong Li, Primo N Lara, et al.
Translational Lung Cancer Research
|
October 24, 2025
Actionable mutations and targeted therapy in non-small cell lung cancer among Latin American and Hispanic patients: a systematic literature review of prognosis and meta-analysis
Juan Pablo Castañeda-González, Jonathan W Riess, María Paula Gómez-Gómez, et al.
Clinical Lung Cancer
|
February 15, 2014
Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era
Jonathan W Riess, Seema Nagpal, Michael Iv, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 136) with videos related to
Sort By:
Page
of 14
Clinical Lung Cancer
|
August 1, 2024
Current Trial Report: A Multicenter Phase I/Ib study of Capmatinib Plus Trametinib in Patients With Metastatic Nonsmall Cell Lung Center Harboring MET Exon 14 Skipping Mutations and Other MET-Alterations
Matthew S Lara, Jonathan W Riess, Jonathan W Goldman, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 8, 2015
Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug-drug interaction
Millie Das, Sukhmani K Padda, Adam Frymoyer, et al.
The Oncologist
|
March 16, 2018
Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck
Vanessa Trieu, Harlan Pinto, Jonathan W Riess, et al.
Arzneimittel-Forschung
|
July 1, 1986
[The percutaneous absorption of diclofenac]
W Riess, K Schmid, L Botta, et al.
Anticancer Research
|
February 11, 2015
GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray
Jonathan W Riess, Robert West, Michelle Dean, et al.
JTO Clinical and Research Reports
|
September 10, 2025
Older Adult Participation in Early-Phase Lung Cancer Clinical Trials, 1998 to 2020
Desirae Ehley, Lilit Vardanyan, Rebecca S Boxer, et al.
Npj Metabolic Health and Disease
|
May 27, 2024
Potential roles of sex-linked differences in obesity and cancer immunotherapy: revisiting the obesity paradox
Logan V Vick, Spencer Rosario, Jonathan W Riess, et al.
Clinical Lung Cancer
|
November 2, 2013
Acquired resistance to targeted therapies against oncogene-driven non-small-cell lung cancer: approach to subtyping progressive disease and clinical implications
David R Gandara, Tianhong Li, Primo N Lara, et al.
Translational Lung Cancer Research
|
October 24, 2025
Actionable mutations and targeted therapy in non-small cell lung cancer among Latin American and Hispanic patients: a systematic literature review of prognosis and meta-analysis
Juan Pablo Castañeda-González, Jonathan W Riess, María Paula Gómez-Gómez, et al.
Clinical Lung Cancer
|
February 15, 2014
Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era
Jonathan W Riess, Seema Nagpal, Michael Iv, et al.
Page
of 14